Skip to main content
. Author manuscript; available in PMC: 2010 Apr 5.
Published in final edited form as: J Immunol. 2005 Jul 1;175(1):404–412. doi: 10.4049/jimmunol.175.1.404

FIGURE 2.

FIGURE 2

GRO-α (A) and G-CSF (B) secreted after stimulation with IL-17F and/or TNF-α. primary HBE cells were treated with IL-17F (10 ng/ml) and TNF-α (1 ng/ml). The cytokine mixture (IL-17F + TNF-α) was also preincubated with anti-IL-17 mAb (2 μg/ml), recombinant human IL-17R:Fc (1 μg/ml), or isotype-matched controls. Basolateral media were collected 24 h after the treatment, and cytokine levels were determined by ELISA. Results are expressed as the mean ± SEM of triplicate samples from one representative experiment (*, p < 0.05). C, G-CSF secreted after stimulation with IL-17A (10 ng/ml) and/or TNF-α. Cells were treated as outlined above. Results are expressed as the mean ± SEM of triplicate samples from one representative experiment (*, p < 0.05).